FXH vs. CNCR

Last updated Jun 4, 2026

FXH (First Trust Health Care AlphaDEX Fund) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds - FXH tracks the StrataQuant Health Care Index while CNCR tracks the Loncar Cancer Immunotherapy Index. Both are passively managed. FXH charges 0.61%/yr vs 0.79%/yr for CNCR.

Performance

FXH vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Health Care AlphaDEX Fund (FXH) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

FXH

• 1D: 1.48%
• 1M: 1.65%
• YTD: 0.68%
• 6M: -0.88%
• 1Y: 13.28%
• 3Y*: 3.52%
• 5Y*: 0.56%
• 10Y*: 7.03%

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

FXH vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
FXH First Trust Health Care AlphaDEX Fund	-1.03%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

FXH vs. CNCR - Sectors Allocation Comparison

Sectors	FXH	CNCR
Healthcare	100.0%	96.6%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	3.3%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

FXH vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FXH

FXH Risk / Return Rank: 24
FXH Sharpe Ratio Rank: 24
FXH Sortino Ratio Rank: 24
FXH Omega Ratio Rank: 23
FXH Calmar Ratio Rank: 24
FXH Martin Ratio Rank: 25

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FXH vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Health Care AlphaDEX Fund (FXH) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FXH	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	0.85	—	—
Sortino ratio: Return per unit of downside risk	1.34	—	—
Omega ratio: Gain probability vs. loss probability	1.15	—	—
Calmar ratio: Return relative to maximum drawdown	1.09	—	—
Martin ratio: Return relative to average drawdown	3.33	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	FXH	CNCR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.85	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.03	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.38	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.51	—	—

Drawdowns

FXH vs. CNCR - Drawdown Comparison

The maximum FXH drawdown since its inception was -43.70%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for FXH and CNCR.

Drawdown Indicators

	FXH	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-43.70%	0.00%	-43.70%
Max Drawdown (1Y) Largest decline over 1 year	-12.20%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-17.53%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-29.49%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-30.61%	—	—
Current Drawdown Current decline from peak	-9.07%	0.00%	-9.07%
Average Drawdown Average peak-to-trough decline	-9.46%	0.00%	-9.46%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.99%	—	—

Volatility

Volatility by Period

	FXH	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.16%	—	—
Volatility (6M) Calculated over the trailing 6-month period	11.17%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	15.75%	0.00%	+15.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.52%	0.00%	+16.52%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.47%	0.00%	+18.47%

FXH vs. CNCR - Expense Ratio Comparison

FXH has a 0.61% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

FXH vs. CNCR - Dividend Comparison

FXH's dividend yield for the trailing twelve months is around 0.85%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%
FXH First Trust Health Care AlphaDEX Fund	0.85%	0.75%	0.41%	0.24%	0.20%

Frequently Asked Questions

Which ETF is better, FXH or CNCR?

On fees, FXH is cheaper at 0.61% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, FXH or CNCR?

FXH is cheaper with a 0.61% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, FXH or CNCR?

FXH has the higher dividend yield at 0.85%, compared with 0.00% for CNCR.

What is the main difference between FXH and CNCR?

FXH tracks StrataQuant Health Care Index, while CNCR tracks Loncar Cancer Immunotherapy Index. They also come from different issuers: First Trust and Exchange Traded Concepts. Their fees differ too: 0.61% for FXH and 0.79% for CNCR.